Zobrazeno 1 - 10
of 11
pro vyhledávání: '"La Madrid AM"'
Autor:
Gómez-González S; Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Llano J; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.; B2SLab, Departament d'Enginyeria de Sistemes, Automàtica i Informàtica Industrial, Universitat Politècnica de Catalunya, Barcelona, Spain.; Networking Biomedical Research Centre in the Subject Area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain., Garcia M; Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Garrido-Garcia A; Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Suñol M; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain., Lemos I; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Perez-Jaume S; Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Salvador N; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Gene-Olaciregui N; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Galán RA; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain., Santa-María V; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Perez-Somarriba M; Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, UK., Castañeda A; Pediatric Solid Tumor Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Hinojosa J; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., Winter U; Department of Pathology, Pediatric Hospital S.A.M.I.C. Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Moreira FB; Department of Pathology, Pediatric Hospital S.A.M.I.C. Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Lubieniecki F; Department of Pathology, Pediatric Hospital S.A.M.I.C. Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Vazquez V; Department of Pathology, Pediatric Hospital S.A.M.I.C. Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Mora J; Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Pediatric Solid Tumor Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Cruz O; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., La Madrid AM; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Perera A; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.; B2SLab, Departament d'Enginyeria de Sistemes, Automàtica i Informàtica Industrial, Universitat Politècnica de Catalunya, Barcelona, Spain.; Networking Biomedical Research Centre in the Subject Area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain., Lavarino C; Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
Publikováno v:
IScience [iScience] 2023 Aug 12; Vol. 26 (9), pp. 107598. Date of Electronic Publication: 2023 Aug 12 (Print Publication: 2023).
Autor:
Erker C; Division of Hematology/Oncology, Department of Paediatrics, IWK Health Centre and Dalhousie University, Halifax, NS, Canada., Mynarek M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bailey S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle-upon-Tyne, United Kingdom., Mazewski CM; Children's Healthcare of Atlanta & Emory University, Atlanta, GA., Baroni L; Hospital of Pediatrics SAMIC Prof. Dr Juan P. Garrahan, Buenos Aires, Argentina., Massimino M; Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy., Hukin J; Divisions of Neurology and Hematology, Oncology/ Bone Marrow Transplant, Department of Pediatrics, British Columbia Children's Hospital and University of British Columbia, Vancouver, BC, Canada., Aguilera D; Children's Healthcare of Atlanta & Emory University, Atlanta, GA., Cappellano AM; Division of Pediatric Oncology/BMT, Instituto de Oncologia Pediátrica-GRAACC-UNIFESP, São Paulo, Brazil., Ramaswamy V; Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada., Lassaletta A; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Perreault S; Centre Hospitalier Universitaire Sainte, Justine, Université de Montreal, Montreal, QC, Canada., Kline CN; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA., Rajagopal R; Division of Hematology-Oncology, Department of Pediatrics, University Malaya Medical Center, Kuala Lumpur, Malaysia., Michaiel G; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Keck School of Medicine of University of Southern California, Los Angeles, CA., Zapotocky M; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Santa-Maria Lopez V; Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., La Madrid AM; Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Cacciotti C; Division of Pediatric Hematology/Oncology, Western University, London, ON, Canada.; Dana Farber/Boston Children's Cancer and Blood Disorder Center, Boston, MA., Sandler ES; Nemours Children's Health, Wolfson's Children's Hospital & University of Florida, Jacksonville, FL., Hoffman LM; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ., Klawinski D; Nemours Children's Health, Wolfson's Children's Hospital & University of Florida, Jacksonville, FL., Khan S; Monash Children's Cancer Centre, Monash Children's Hospital. Monash Health. Center for Cancer Research, Hudson Institute of Medical Research, and Department of Molecular and Translational Science, School of Medicine, Nursing and Health Science, Monash University, Melbourne, Australia.; Division of Hematology, Oncology & Bone Marrow Transplant, Nationwide Children's Hospital, The Ohio State University, Columbus, OH., Salloum R; Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada., Hoppmann AL; Department of Pediatrics, Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL., Larouche V; Department of Pediatrics, Centre Mère-enfant Soleil du CHU de Québec, CRCHU de Québec, Université Laval, Quebec City, QC, Canada., Dorris K; Children's Hospital of Colorado & University of Colorado School of Medicine, Denver, CO., Toledano H; Schneider Children's Medical Center of Israel, Petah Tikva, and Sackler faculty of Medicine, Tel Aviv University, Israel., Gilheeney SW; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY., Abdelbaki MS; Division of Hematology, Oncology and Blood and Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, OH.; Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine in St Louis, St Louis, MO., Wilson B; Department of Pediatrics, Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada., Tsang DS; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Knipstein J; Division of Pediatric Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI., Oren MY; Pediatric Hemato-Oncology Department, Sheba Medical Center at Tel HaShomer, Ramat Gan, Israel., Shah S; The University of Texas Health Science Center, Department of Pediatric Hematology-Oncology, San Antonio, TX., Murray JC; Division of Pediatric Hematology/Oncology, Cook Children's Medical Center, Fort Worth, TX., Ginn KF; Division of Pediatric Hematology and Oncology, Children's Mercy Hospital, Kansas City, MO., Wang ZJ; Division of Hematology and Oncology, Children's Hospital of Richmond and Virginia Commonwealth University, Richmond, VA., Fleischhack G; Pediatric Hematology and Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany., Obrecht D; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Tonn S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Harrod VL; Departments of Pediatric Hematology and Oncology, Dell Children's Medical Center of Central Texas and University of Texas, Austin, TX., Matheson K; Research Methods Unit, Nova Scotia Health Authority, Halifax, NS, Canada., Crooks B; Division of Haematology/Oncology, Department of Paediatrics, IWK Health Centre and Dalhousie University, Halifax, NS, Canada., Strother DR; Section of Pediatric Hematology and Bone Marrow Transplantation, Alberta Children's Hospital, Calgary, AB, Canada., Cohen KJ; Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Hansford JR; Children's Cancer Centre, Royal Children's Hospital; Murdoch Children's Research Institute; University of Melbourne, Melbourne, Australia., Mueller S; Department of Pediatrics, University of California San Francisco, San Francisco, CA., Margol A; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Keck School of Medicine of University of Southern California, Los Angeles, CA., Gajjar A; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN., Dhall G; Division of Hematology, Oncology & Bone Marrow Transplant, Nationwide Children's Hospital, The Ohio State University, Columbus, OH., Finlay JL; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY., Northcott PA; Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Clifford SC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle-upon-Tyne, United Kingdom., Robinson G; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN., Bouffet E; Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada., Lafay-Cousin L; Section of Pediatric Hematology and Bone Marrow Transplantation, Alberta Children's Hospital, Calgary, AB, Canada.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Apr 01; Vol. 41 (10), pp. 1921-1932. Date of Electronic Publication: 2022 Dec 22.
Autor:
Gene-Olaciregui N; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Perez-Somarriba M; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Santa-María V; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Cruz O; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Gómez-González S; Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Castañeda A; Pediatric Solid Tumor Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Suñol M; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain., Rovira C; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain., Muchart J; Department of Radiology, Hospital Sant Joan de Déu, Barcelona, Spain., Hinojosa J; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., La Madrid AM; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Lavarino C; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Mar; Vol. 7, pp. e2200547.
Autor:
Duchatel RJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Mannan A; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Woldu AS; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Hawtrey T; School of Chemistry, University of New South Wales, Sydney, New South Wales, Australia., Hindley PA; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Jewells Medical Centre, Jewells, New South Wales, Australia., Douglas AM; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Jackson ER; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Findlay IJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Germon ZP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Staudt D; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Kearney PS; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Smith ND; Analytical and Biomolecular Research Facility, Advanced Mass Spectrometry Unit, University of Newcastle, Callaghan, New South Wales, Australia., Hindley KE; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Sash Small Animal Specialist Hospital, Tuggerah, New South Wales, Australia., Cain JE; Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., André N; Department of Pediatric Oncology, La Timone Children's Hospital, AP-HM, Marseille, France.; SMARTc Unit, Centre de Recherche en Cancérologie de Marseille, Inserm U1068, Aix Marseille Univ, Marseille, France., La Madrid AM; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Neuro-Oncology Unit, Hospital Sant Joan de Déu, Barcelona, Spain., Nixon B; Reproductive Science Group, College of Engineering, Science and Environment, University of Newcastle, Callaghan, New South Wales, Australia., De Iuliis GN; Reproductive Science Group, College of Engineering, Science and Environment, University of Newcastle, Callaghan, New South Wales, Australia., Nazarian J; Children's National Medical Center, Washington, District of Columbia., USA.; University Children's Hospital Zurich, Zurich, Switzerland., Irish K; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia., Alvaro F; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia., Eisenstat DD; Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.; Neuro-Oncology Laboratory, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia., Beck A; Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany., Vitanza NA; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington, USA., Mueller S; University Children's Hospital Zurich, Zurich, Switzerland.; Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, California, USA., Morris JC; School of Chemistry, University of New South Wales, Sydney, New South Wales, Australia., Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2021 Nov 19; Vol. 3 (1), pp. vdab169. Date of Electronic Publication: 2021 Nov 19 (Print Publication: 2021).
Autor:
Rosabal-Obando M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Osorio DS; Neuro-Oncology Program, Division of Hematology, Oncology and BMT, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio, USA., Lassaletta A; Pediatric Oncology, Hematology and Stem Cell Transplant Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., La Madrid AM; Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Bartels U; Neuro-Oncology, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Finlay JL; Neuro-Oncology Program, Division of Hematology, Oncology and BMT, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio, USA., Qaddoumi I; Global Pediatric Medicine Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mynarek M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Sep; Vol. 68 (9), pp. e29073. Date of Electronic Publication: 2021 May 18.
Autor:
Pérez JPM; Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Muchart J; Pediatric Neuroradiology Unit, Hospital Sant Joan de Déu, Barcelona, Spain., López VS; Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Pediatric Neuro-Oncology Unit, Department of Oncology, Hospital Sant Joan de Déu, Passeig Sant Joan de Deu 2, 08950, Barcelona, Spain., Capella MS; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain., Salvador N; Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Barcelona, Spain., Jaume SP; Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Barcelona, Spain., Martínez OC; Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Pediatric Neuro-Oncology Unit, Department of Oncology, Hospital Sant Joan de Déu, Passeig Sant Joan de Deu 2, 08950, Barcelona, Spain., La Madrid AM; Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain. amorales@sjdhospitalbarcelona.org.; Pediatric Neuro-Oncology Unit, Department of Oncology, Hospital Sant Joan de Déu, Passeig Sant Joan de Deu 2, 08950, Barcelona, Spain. amorales@sjdhospitalbarcelona.org.
Publikováno v:
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery [Childs Nerv Syst] 2021 Aug; Vol. 37 (8), pp. 2511-2520. Date of Electronic Publication: 2021 Apr 17.
Autor:
Baroni LV; Service of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina., Rugilo C; Service of Diagnostic Imaging, Hospital JP Garrahan, Buenos Aires, Argentina., Lubieniecki F; Service of Pathology, Hospital JP Garrahan, Buenos Aires, Argentina., Sampor C; Service of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina., Freytes C; Service of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina., Nobre L; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada., Hansford JR; Children's Cancer Centre, Royal Children's Hospital, Melbourne, Victoria, Australia.; Division of Cancer, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia., Malalasekera VS; Children's Cancer Centre, Royal Children's Hospital, Melbourne, Victoria, Australia., Zapotocky M; Department of Paediatric Haematology and Oncology, Second Medical School, Charles University and University Hospital Motol, Prague, Czech Republic., Dodgshun A; Children's Haematology/Oncology Centre, Christchurch Hospital, Christchurch, New Zealand., Martinez OC; Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., La Madrid AM; Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Lavarino C; Developmental Tumor Biology Laboratory, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Suñol M; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany., Schuller U; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany., Bouffet E; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada., Ramaswamy V; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.; Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada., Alderete D; Service of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Dec; Vol. 67 (12), pp. e28627. Date of Electronic Publication: 2020 Sep 22.
Autor:
Janin M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Ortiz-Barahona V; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., de Moura MC; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Martínez-Cardús A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Llinàs-Arias P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Soler M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Nachmani D; Department of Medicine and Pathology, Cancer Research Institute, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Pelletier J; Molecular Mechanisms and Experimental Therapy in Oncology Program, Metabolism and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Schumann U; EMBL-Australia Collaborating Group, Department of Genome Sciences, The John Curtin School of Medical Research, The Australian National University, Garran Road, Acton, ACT, 2601, Australia., Calleja-Cervantes ME; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Moran S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Guil S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Bueno-Costa A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Piñeyro D; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Perez-Salvia M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Rosselló-Tortella M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Piqué L; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Bech-Serra JJ; Proteomics Unit, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., De La Torre C; Proteomics Unit, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain., Vidal A; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain., Martínez-Iniesta M; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Oncobell Program, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Martín-Tejera JF; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Oncobell Program, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Villanueva A; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Oncobell Program, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Arias A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain., Cuartas I; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain., Aransay AM; Centro de Investigación Bimédica en Red de Enfermedades hepáticas y Digestivas (CIBERehd), CIC bioGUNE, 801A Bizkaia Technology Park, 48160, Derio, Spain., La Madrid AM; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.; Pediatric Neuro-Oncology Unit, Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain., Carcaboso AM; Preclinical Therapeutics and Drug Delivery Research Program, Fundacio Sant Joan de Deu, Barcelona, Catalonia, Spain., Santa-Maria V; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.; Pediatric Neuro-Oncology Unit, Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain., Mora J; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain., Fernandez AF; Institute of Oncology of Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA-FINBA), 33011, Oviedo, Spain., Fraga MF; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Oviedo, Spain., Aldecoa I; Pathology-Brain Bank, Hospital Clínic de Barcelona-CDB-August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Catalonia, Spain., Pedrosa L; Glioma and Neural Stem Cell Group and Translational Genomics and Targeted Therapeutics in Solid Tumors Team, IDIBAPS, Barcelona, Catalonia, Spain., Graus F; Clinical and Experimental Neuroimmunology, IDIBAPS, Barcelona, Catalonia, Spain., Vidal N; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Martínez-Soler F; Faculty of Medicine and Health Sciences-Bellvitge, Universitat de Barcelona, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Tortosa A; Faculty of Medicine and Health Sciences-Bellvitge, Universitat de Barcelona, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Carrato C; Department of Pathology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain., Balañá C; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, 08916, Badalona, Barcelona, Catalonia, Spain., Boudreau MW; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA., Hergenrother PJ; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA., Kötter P; Institute for Molecular Biosciences, Goethe University, Frankfurt, Germany., Entian KD; Institute for Molecular Biosciences, Goethe University, Frankfurt, Germany., Hench J; Division of Neuropathology, Institute of Medical Genetics and Pathology, University Hospital Basel, 4031, Basel, Switzerland., Frank S; Division of Neuropathology, Institute of Medical Genetics and Pathology, University Hospital Basel, 4031, Basel, Switzerland., Mansouri S; Division of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada., Zadeh G; Division of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada., Dans PD; Joint IRB-BSC Program on Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Catalonia, Spain., Orozco M; Joint IRB-BSC Program on Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Catalonia, Spain.; Department of Biochemistry and Biomedicine, University of Barcelona, 08028, Barcelona, Spain., Thomas G; Molecular Mechanisms and Experimental Therapy in Oncology Program, Metabolism and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati Medical School, Cincinnati, OH, 45267-0508, USA., Blanco S; CIC bioGUNE, 801A Bizkaia Technology Park, 48160, Derio, Spain.; Molecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC), University of Salamanca, 37007, Salamanca, Spain., Seoane J; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain., Preiss T; EMBL-Australia Collaborating Group, Department of Genome Sciences, The John Curtin School of Medical Research, The Australian National University, Garran Road, Acton, ACT, 2601, Australia.; Victor Chang Cardiac Research Institute, Darlinghurst (Sydney), NSW, 2010, Australia., Pandolfi PP; Department of Medicine and Pathology, Cancer Research Institute, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain. mesteller@carrerasresearch.org.; Department of Biochemistry and Biomedicine, University of Barcelona, 08028, Barcelona, Spain. mesteller@carrerasresearch.org.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916, Badalona, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2019 Dec; Vol. 138 (6), pp. 1053-1074. Date of Electronic Publication: 2019 Aug 19.
Autor:
Benitez-Ribas D; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Cabezón R; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Flórez-Grau G; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Molero MC; Department of Clinical Trials, Hospital Sant Joan de Déu, Barcelona, Spain., Puerta P; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., Guillen A; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., Paco S; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Carcaboso AM; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Santa-Maria Lopez V; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Cruz O; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., de Torres C; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Salvador N; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Juan M; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain.; Department of Immunotherapy, Hospital Sant Joan de Déu, Barcelona, Spain., Mora J; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., La Madrid AM; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2018 Apr 26; Vol. 8, pp. 127. Date of Electronic Publication: 2018 Apr 26 (Print Publication: 2018).
Autor:
La Madrid AM; Pediatric Neuro-Oncology, Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona, Spain., Kieran MW; The Pediatric Brain Tumor Center, Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, United States.
Publikováno v:
Current cancer drug targets [Curr Cancer Drug Targets] 2018; Vol. 18 (1), pp. 57-64.